Novatio Ventures is a venture capital firm that accelerates the commercialization of high-potential, high-impact life science innovations. The firm is based in Toronto, Ontario and focuses on the global development of innovations arising from Canada, China, South Korea and other markets that represents a significant source of opportunities for out sized value creation. It invests in firms operating in the therapeutics, diagnostics, devices and drug delivery technologies.